ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,691 | -20.4% | 3,846 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $32,268 | +89.8% | 3,846 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $17,000 | +13.3% | 3,805 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,000 | -54.5% | 3,805 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $33,000 | -23.3% | 3,805 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $43,000 | +1333.3% | 3,805 | +174.1% | 0.00% | – |
| Q1 2020 | $3,000 | -62.5% | 1,388 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +14.3% | 1,388 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 1,388 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -38.5% | 1,388 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | +8.3% | 1,388 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -36.8% | 1,388 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $19,000 | +72.7% | 1,388 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | – | 1,388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
| Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
| ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
| Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
| Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
| Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
| Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
| APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
| JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
| Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |